BioCentury
ARTICLE | Clinical News

Velneperit: Phase IIb data

February 23, 2009 8:00 AM UTC

Shionogi & Co. Ltd., Osaka, Japan Product: Velneperit ( S-2367) Business: Endocrine Molecular target: Neuropeptide Y receptor Y5 (NPY5R) Description: Oral neuropeptide Y (NPY) Y5 receptor antagonis...